Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Return on Equity (2019 - 2025)

Bioadaptives' Return on Equity history spans 7 years, with the latest figure at 0.89% for Q3 2025.

  • For Q3 2025, Return on Equity rose 76.0% year-over-year to 0.89%; the TTM value through Sep 2025 reached 0.89%, up 76.0%, while the annual FY2024 figure was 0.45%, 27.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.89% at Bioadaptives, up from 0.61% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.91% in Q1 2021 and bottomed at 0.13% in Q3 2024.
  • The 5-year median for Return on Equity is 0.53% (2025), against an average of 0.52%.
  • The largest annual shift saw Return on Equity crashed -38bps in 2022 before it skyrocketed 76bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.8% in 2021, then decreased by -29bps to 0.57% in 2022, then crashed by -56bps to 0.25% in 2023, then skyrocketed by 57bps to 0.4% in 2024, then soared by 122bps to 0.89% in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Return on Equity are 0.89% (Q3 2025), 0.61% (Q2 2025), and 0.53% (Q1 2025).